OBJECTIVES: We evaluated changes in characteristics of clients presenting for voluntary counseling and testing (VCT) before and during care and treatment center (CTC) scale-up activities in Moshi, Tanzania, between November 2003 and December 2007. METHODS: Consecutive clients were surveyed after pretest counseling, and rapid HIV antibody testing was performed. Trend tests were used to assess changes in seroprevalence and client characteristics over time. Multivariable logistic regression models were used to estimate the contribution of changes in sociodemographic and behavioral risk characteristics, and symptoms, to changes in seroprevalence before and during CTC scale-up. RESULTS: Data from 4391 first-time VCT clients were analyzed. HIV seroprevalence decreased from 26.2% to 18.9% after the availability of free antiretroviral therapy and expansion of CTCs beyond regional and referral hospitals. Seroprevalence decreased by 27 % for females (P = 0.0002) and 34% for males (P = 0.0125). Declines in seropositivity coincided with decreases in symptoms among males and females (P < 0.0001) and a more favorable distribution of sociodemographic risks among females (P = 0.002). No changes in behavioral risk characteristics were observed. CONCLUSIONS: Concurrent with the scale-up of CTCs, HIV seroprevalence and rates of symptoms declined sharply at an established freestanding VCT site in Moshi, Tanzania. If more HIV-infected persons access VCT at sites where antiretrovirals are offered, freestanding VCT sites may become a less cost-effective means for HIV case finding.
OBJECTIVES: We evaluated changes in characteristics of clients presenting for voluntary counseling and testing (VCT) before and during care and treatment center (CTC) scale-up activities in Moshi, Tanzania, between November 2003 and December 2007. METHODS: Consecutive clients were surveyed after pretest counseling, and rapid HIV antibody testing was performed. Trend tests were used to assess changes in seroprevalence and client characteristics over time. Multivariable logistic regression models were used to estimate the contribution of changes in sociodemographic and behavioral risk characteristics, and symptoms, to changes in seroprevalence before and during CTC scale-up. RESULTS: Data from 4391 first-time VCT clients were analyzed. HIV seroprevalence decreased from 26.2% to 18.9% after the availability of free antiretroviral therapy and expansion of CTCs beyond regional and referral hospitals. Seroprevalence decreased by 27 % for females (P = 0.0002) and 34% for males (P = 0.0125). Declines in seropositivity coincided with decreases in symptoms among males and females (P < 0.0001) and a more favorable distribution of sociodemographic risks among females (P = 0.002). No changes in behavioral risk characteristics were observed. CONCLUSIONS: Concurrent with the scale-up of CTCs, HIV seroprevalence and rates of symptoms declined sharply at an established freestanding VCT site in Moshi, Tanzania. If more HIV-infectedpersons access VCT at sites where antiretrovirals are offered, freestanding VCT sites may become a less cost-effective means for HIV case finding.
Authors: Peter Godfrey-Faussett; Dermot Maher; Ya Diul Mukadi; Paul Nunn; Joseph Perriëns; Mario Raviglione Journal: Bull World Health Organ Date: 2003-01-23 Impact factor: 9.408
Authors: Joshua A Salomon; Daniel R Hogan; John Stover; Karen A Stanecki; Neff Walker; Peter D Ghys; Bernhard Schwartländer Journal: PLoS Med Date: 2005-01-11 Impact factor: 11.069
Authors: Suzanne P Fiorillo; Keren Z Landman; Alison C Tribble; Antipas Mtalo; Dafrosa K Itemba; Jan Ostermann; Nathan M Thielman; John A Crump Journal: AIDS Care Date: 2012-03-01
Authors: Kartik K Venkatesh; Precious Madiba; Guy De Bruyn; Mark N Lurie; Thomas J Coates; Glenda E Gray Journal: J Acquir Immune Defic Syndr Date: 2011-02-01 Impact factor: 3.731
Authors: Jan Ostermann; Kathryn Whetten; Elizabeth Reddy; Brian Pence; Andrew Weinhold; Dafrosa Itemba; Venance Maro; Eligy Mosille; Nathan Thielman Journal: AIDS Care Date: 2014-02-11
Authors: Jan Ostermann; Elizabeth A Reddy; Meghan M Shorter; Charles Muiruri; Antipas Mtalo; Dafrosa K Itemba; Bernard Njau; John A Bartlett; John A Crump; Nathan M Thielman Journal: PLoS One Date: 2011-01-31 Impact factor: 3.240
Authors: Bernard Njau; Jan Ostermann; Derek Brown; Axel Mühlbacher; Elizabeth Reddy; Nathan Thielman Journal: BMC Public Health Date: 2014-08-12 Impact factor: 3.295